Infertility Market: A Lucrative Opportunity Analysis
Infertility is a medical condition in which male, or female members are unable to reproduce or have children. Common conditions for the condition include low sperm motility, genetic deficiencies, and psychological issues. According to the Centers for Disease Control & Prevention (CDC), close to 6% unmarried women are unable to attain pregnancy even after unprotected intercourse. The global infertility market report compiled by Market Research Future (MRFR) contains pertinent factors and challenges of customers as well as efforts of industry stalwarts in easing the process of reproduction.
The Infertility Market Share is anticipated to grow at CAGR of 12.8 % and will reach a valuation of USD 4.72 billion during the forecast period 2023-2032.
Major growth drivers of the market include late marriages, sedentary lifestyles, genetic deficiencies, environmental factors, and health history.
Infertility Market Outlook
Awareness of the condition and preventive measures in terms of treatment is likely to drive the market growth. Emergence of various clinics which can conduct tests discreetly can bode well for the market. In addition, the recognition of infertility as a disease by insurance organizations and coverage packages being dispensed to patients is a sign of the large potential of the market. Technological advances in terms of artificial reproduction technique (ART) and artificial insemination are predicted to bolster the global infertility market growth. Successful outcomes of such methods as well as conduction of clinical trials for safe methods of conception among couples are other major drivers of the market.
High Infertility treatment costs, side effects of infertility treatment, and societal taboos are factors which can impede market growth.
Competitive Outlook-
Olympus Corporation, The Cooper Companies Inc., Virtus Health, CooperSurgical, Inc., Vitro life CARE Fertility
Infertility Market Segmentation Analysis
The global infertility market outlook report is segmented by sex, diagnosis, drugs, and techniques.
By sex, it is segmented into male, female, and unexplained.
By diagnosis, it is segmented infertility statistics worldwide into men diagnostic tests, female diagnostic tests, and general diagnostic tests. Testicular biopsy, genetic testing, semen analysis, and others are major sub-segments within the men diagnostic tests segment. Female diagnostic tests, on the other hand, is segmented into hysterosalpingography, hysteroscopy, laparoscopy, ovulation testing, and others. Microscopic analysis, imaging, hormone testing, genetic testing, and others are segments within general diagnostic tests.
By drugs, it is segmented into seraphine, clomiphene citrate, letrozole, hormone treatment, and others.
By techniques, it is segmented into assisted reproductive technology (ART), surgery, and intrauterine insemination. Surgery is further segmented into tubal surgeries, laparoscopic or hysteroscopic surgery, and others.
Infertility Market Regional Analysis
North America, Asia Pacific, Europe, and the Middle East & Africa (MEA) are the regions being considered for the basis of the report.
North America is predicted to dominate the market led by the U.S. Factors facilitating regional market growth include rise in awareness levels of patients, high expendable income levels of patients, and reimbursement schemes.
Europe is expected to be the second largest region led by France, Germany, and the U.K. Changes in lifestyles of patients and delayed pregnancies are factors which can drive the need for fertility treatments. In addition, the successful outcomes of fertility clinics as well as rise in cryopreservation can contribute to the global infertility treatment in Paris.
For More Information, Please Visit @ Market Research Future
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian